Crossmark

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s12951-021-01095-w

Published Online: 2021-11-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhe

Yang, Gang

Han, Lu

Wang, Rong

Gong, Chunai

Yuan, Yongfang
Funding

Funding for this research was provided by:

national natural science foundation of china (NO. 81903141)

shanghai sailing program (No.20YF1424000, No.21YF1422700)
License Information

Text and Data Mining valid from 2021-11-08

Version of Record valid from 2021-11-08
More Information

Article History

Received: 3 August 2021

Accepted: 18 October 2021

First Online: 8 November 2021

Declarations

:

: The authors declare that they have no competing financial interests.

Document is current

Any future updates will be listed below